What Happened
In August 2024, Dexter Prescription Center, also known as Dexter Pharmacy, of Buffalo, New York, agreed to pay the United States $141,727 to resolve allegations that it violated the record keeping provisions of the Controlled Substances Act and overcharged federal health care programs. A DEA inspection found that between January 1, 2018, and February 1, 2021, the pharmacy failed to maintain accurate records of its purchases and sales of certain controlled substances. It also billed federal programs for medications, including controlled substances, that it never dispensed. The settlement is not an admission of liability by the pharmacy.
“Dexter Pharmacy failed to maintain accurate records relating to its purchases and sales for certain controlled substances”
Related Guidance
- 15 Red Flags of Drug Diversion — Behavioral and transactional indicators of diversion.
- Investigation Playbook — How to investigate suspected diversion inside an organization.